Comprehensively, our results indicate that, although differently, the expression of the AMBRA1 L110F and P170S mutants, predicted to be pathogenic, accelerates the wound closure capacity of melanoma cells and activates the EMT process and the FAK1 oncogenic signaling pathway. This evidence concerns the gene AMBRA1 and melanoma.